scispace - formally typeset
D

Dillip Kumar Bishi

Researcher at Rama Devi Women's College

Publications -  22
Citations -  328

Dillip Kumar Bishi is an academic researcher from Rama Devi Women's College. The author has contributed to research in topics: Mesenchymal stem cell & Stem cell. The author has an hindex of 8, co-authored 21 publications receiving 241 citations. Previous affiliations of Dillip Kumar Bishi include Indian Institute of Technology Madras & National University of Singapore.

Papers
More filters
Journal ArticleDOI

Trans-differentiation of human mesenchymal stem cells generates functional hepatospheres on poly(L-lactic acid)-co-poly(ε-caprolactone)/collagen nanofibrous scaffolds

TL;DR: PLACL/collagen nanofibrous scaffolds are potentially biomimetic and upon sequential induction with hepatogenic growth factors/cytokines, it augments trans-differentiation of hMSCs towards functional hepatosphere formation.
Journal ArticleDOI

Molecular Analysis of Coagulase Gene Polymorphism in Clinical Isolates of Methicilin Resistant Staphylococcus aureus by Restriction Fragment Length Polymorphism Based Genotyping

TL;DR: Method investigated in this study, proved to be efficient, reliable and useful for typing large number of MRSA strains from various clinical isolates with high fidelity and improved the discriminatory index.
Journal ArticleDOI

Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering

TL;DR: Lyophilized acellular detoxified GLUT cross-linked bovine pericardium, employed in this study as an alternative to conventional GLUTCross- linked bovines, might provide longer durability and better biocompatibility, and reduce calcification.
Journal ArticleDOI

Recent trends in biodegradable polyester nanomaterials for cancer therapy.

TL;DR: In this article, a review of the chemical synthesis of different synthetic polyesters and their use as nanodrug carriers (NCs) in cancer treatment is discussed, highlighting the recent developments of metal-free semi-aromatic polyester nanomaterials along with its role as cancer drug delivery vehicles.
Journal ArticleDOI

A Patient-Inspired Ex Vivo Liver Tissue Engineering Approach with Autologous Mesenchymal Stem Cells and Hepatogenic Serum.

TL;DR: The fibrous mesh‐hepatocyte construct developed in this study using natural growth factors and BMSCs of same individual is promising for future therapeutic applications in treating damaged livers.